
Joseph R. Kosack
Examiner (ID: 5528, Phone: (571)272-5575 , Office: P/1626 )
| Most Active Art Unit | 1626 |
| Art Unit(s) | 3991, 1626 |
| Total Applications | 1852 |
| Issued Applications | 1292 |
| Pending Applications | 108 |
| Abandoned Applications | 470 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 17784592
[patent_doc_number] => 11407704
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-08-09
[patent_title] => Process of vitamin K
[patent_app_type] => utility
[patent_app_number] => 17/045477
[patent_app_country] => US
[patent_app_date] => 2019-04-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9147
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17045477
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/045477 | Process of vitamin K | Apr 5, 2019 | Issued |
Array
(
[id] => 14962939
[patent_doc_number] => 20190308947
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-10-10
[patent_title] => INHIBITORS OF RHO/MRTF/SRF-MEDIATED GENE TRANSCRIPTION AND METHODS FOR USE OF THE SAME
[patent_app_type] => utility
[patent_app_number] => 16/376349
[patent_app_country] => US
[patent_app_date] => 2019-04-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22166
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16376349
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/376349 | Inhibitors of Rho/MRTF/SRF-mediated gene transcription and methods for use of the same | Apr 4, 2019 | Issued |
Array
(
[id] => 14836167
[patent_doc_number] => 20190276484
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-09-12
[patent_title] => COMPOSITIONS AND METHODS COMPRISING OSMIUM FOR THE TREATMENT OF CANCERS
[patent_app_type] => utility
[patent_app_number] => 16/365561
[patent_app_country] => US
[patent_app_date] => 2019-03-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23066
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16365561
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/365561 | Compositions and methods comprising osmium for the treatment of cancers | Mar 25, 2019 | Issued |
Array
(
[id] => 18187695
[patent_doc_number] => 11578266
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-02-14
[patent_title] => Silyl phosphine compound, process for producing silyl phosphine compound and process for producing InP quantum dots
[patent_app_type] => utility
[patent_app_number] => 16/979340
[patent_app_country] => US
[patent_app_date] => 2019-03-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12382
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 492
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16979340
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/979340 | Silyl phosphine compound, process for producing silyl phosphine compound and process for producing InP quantum dots | Mar 19, 2019 | Issued |
Array
(
[id] => 14501977
[patent_doc_number] => 20190194643
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-06-27
[patent_title] => Magnetic Ionic Liquids, Methods of Making and Uses Thereof as Solvents in the Extraction and Preservation of Nucleic Acids
[patent_app_type] => utility
[patent_app_number] => 16/295581
[patent_app_country] => US
[patent_app_date] => 2019-03-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15478
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16295581
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/295581 | Magnetic ionic liquids, methods of making and uses thereof as solvents in the extraction and preservation of nucleic acids | Mar 6, 2019 | Issued |
Array
(
[id] => 15540723
[patent_doc_number] => 10570126
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-02-25
[patent_title] => Substituted fused imidazole derivatives, pharmaceutical compositions, and methods of use thereof
[patent_app_type] => utility
[patent_app_number] => 16/292524
[patent_app_country] => US
[patent_app_date] => 2019-03-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 51456
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 84
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16292524
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/292524 | Substituted fused imidazole derivatives, pharmaceutical compositions, and methods of use thereof | Mar 4, 2019 | Issued |
Array
(
[id] => 16028049
[patent_doc_number] => 10676431
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-06-09
[patent_title] => Phenylpyrrolidinone formyl peptide 2 receptor agonists
[patent_app_type] => utility
[patent_app_number] => 16/291209
[patent_app_country] => US
[patent_app_date] => 2019-03-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30304
[patent_no_of_claims] => 53
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 5
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16291209
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/291209 | Phenylpyrrolidinone formyl peptide 2 receptor agonists | Mar 3, 2019 | Issued |
Array
(
[id] => 14836021
[patent_doc_number] => 20190276411
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-09-12
[patent_title] => Method for Producing Radiopharmaceutical Composition
[patent_app_type] => utility
[patent_app_number] => 16/288855
[patent_app_country] => US
[patent_app_date] => 2019-02-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4533
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 111
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16288855
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/288855 | Method for producing radiopharmaceutical composition | Feb 27, 2019 | Issued |
Array
(
[id] => 18871096
[patent_doc_number] => 11858881
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-01-02
[patent_title] => Method for purifying nitrile solvent
[patent_app_type] => utility
[patent_app_number] => 16/975317
[patent_app_country] => US
[patent_app_date] => 2019-02-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3870
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 96
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16975317
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/975317 | Method for purifying nitrile solvent | Feb 25, 2019 | Issued |
Array
(
[id] => 14468061
[patent_doc_number] => 20190185673
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-06-20
[patent_title] => Bis-Azo Colorants For Use As Bluing Agents
[patent_app_type] => utility
[patent_app_number] => 16/281248
[patent_app_country] => US
[patent_app_date] => 2019-02-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10722
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 187
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16281248
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/281248 | Bis-azo colorants for use as bluing agents | Feb 20, 2019 | Issued |
Array
(
[id] => 15913133
[patent_doc_number] => 10653788
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-05-19
[patent_title] => Conjugates of tumor necrosis factor inhibitors to functionalized polymers
[patent_app_type] => utility
[patent_app_number] => 16/272930
[patent_app_country] => US
[patent_app_date] => 2019-02-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 35557
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 202
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16272930
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/272930 | Conjugates of tumor necrosis factor inhibitors to functionalized polymers | Feb 10, 2019 | Issued |
Array
(
[id] => 16627813
[patent_doc_number] => 20210046466
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-02-18
[patent_title] => REACTIONS OF OLEFIN DERIVATIVES IN THE PRESENCE OF METHATHESIS CATALYSTS
[patent_app_type] => utility
[patent_app_number] => 16/969379
[patent_app_country] => US
[patent_app_date] => 2019-02-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17555
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16969379
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/969379 | Reactions of olefin derivatives in the presence of methathesis catalysts | Feb 10, 2019 | Issued |
Array
(
[id] => 14403555
[patent_doc_number] => 20190167621
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-06-06
[patent_title] => SOLUTION FOR OPHTHALMOLOGY
[patent_app_type] => utility
[patent_app_number] => 16/268156
[patent_app_country] => US
[patent_app_date] => 2019-02-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2047
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16268156
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/268156 | Solution for ophthalmology | Feb 4, 2019 | Issued |
Array
(
[id] => 17059005
[patent_doc_number] => 11103587
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-08-31
[patent_title] => Multiple oligonucleotide moieties on peptide carrier
[patent_app_type] => utility
[patent_app_number] => 16/265883
[patent_app_country] => US
[patent_app_date] => 2019-02-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 9127
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 148
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16265883
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/265883 | Multiple oligonucleotide moieties on peptide carrier | Jan 31, 2019 | Issued |
Array
(
[id] => 14375089
[patent_doc_number] => 20190161457
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-05-30
[patent_title] => SOLID-SUPPORTED CATALYST FOR CROSS-COUPLING
[patent_app_type] => utility
[patent_app_number] => 16/265386
[patent_app_country] => US
[patent_app_date] => 2019-02-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17896
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16265386
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/265386 | Solid-supported catalyst for cross-coupling | Jan 31, 2019 | Issued |
Array
(
[id] => 14375091
[patent_doc_number] => 20190161458
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-05-30
[patent_title] => ARYL HALIDE CROSS-COUPLING METHOD AND PRODUCT MADE THEREFROM
[patent_app_type] => utility
[patent_app_number] => 16/265425
[patent_app_country] => US
[patent_app_date] => 2019-02-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17894
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16265425
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/265425 | Aryl halide cross-coupling method and product made therefrom | Jan 31, 2019 | Issued |
Array
(
[id] => 16419811
[patent_doc_number] => 20200345009
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-11-05
[patent_title] => Amidine Substituted Benzoyl Derivatives Useful As Herbicides
[patent_app_type] => utility
[patent_app_number] => 16/963061
[patent_app_country] => US
[patent_app_date] => 2019-01-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17091
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 263
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16963061
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/963061 | Amidine substituted benzoyl derivatives useful as herbicides | Jan 15, 2019 | Issued |
Array
(
[id] => 15267229
[patent_doc_number] => 20190382348
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-12-19
[patent_title] => PYRAZOLE DERIVATIVES AS MODULATORS OF HEPATOCYTE GROWTH FACTOR (SCATTER FACTOR) ACTIVITY
[patent_app_type] => utility
[patent_app_number] => 16/245373
[patent_app_country] => US
[patent_app_date] => 2019-01-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30064
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16245373
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/245373 | PYRAZOLE DERIVATIVES AS MODULATORS OF HEPATOCYTE GROWTH FACTOR (SCATTER FACTOR) ACTIVITY | Jan 10, 2019 | Abandoned |
Array
(
[id] => 17156025
[patent_doc_number] => 20210317076
[patent_country] => US
[patent_kind] => A9
[patent_issue_date] => 2021-10-14
[patent_title] => COMPOUNDS WITH ANTIMICROBIAL ACTIVITY
[patent_app_type] => utility
[patent_app_number] => 16/959142
[patent_app_country] => US
[patent_app_date] => 2019-01-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9049
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 74
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16959142
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/959142 | Compounds with antimicrobial activity | Jan 7, 2019 | Issued |
Array
(
[id] => 17156025
[patent_doc_number] => 20210317076
[patent_country] => US
[patent_kind] => A9
[patent_issue_date] => 2021-10-14
[patent_title] => COMPOUNDS WITH ANTIMICROBIAL ACTIVITY
[patent_app_type] => utility
[patent_app_number] => 16/959142
[patent_app_country] => US
[patent_app_date] => 2019-01-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9049
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 74
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16959142
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/959142 | Compounds with antimicrobial activity | Jan 7, 2019 | Issued |